158 related articles for article (PubMed ID: 38128184)
1. The validation of new CHD1L inhibitors as a therapeutic strategy for cancer.
Clune S; Awolade P; Zhou Q; Esquer H; Matter B; Kearns JT; Kellett T; Akintayo DC; Kompella UB; LaBarbera DV
Biomed Pharmacother; 2024 Jan; 170():116037. PubMed ID: 38128184
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L.
Prigaro BJ; Esquer H; Zhou Q; Pike LA; Awolade P; Lai XH; Abraham AD; Abbott JM; Matter B; Kompella UB; Messersmith WA; Gustafson DL; LaBarbera DV
J Med Chem; 2022 Mar; 65(5):3943-3961. PubMed ID: 35192363
[TBL] [Abstract][Full Text] [Related]
3. First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer.
Abbott JM; Zhou Q; Esquer H; Pike L; Broneske TP; Rinaldetti S; Abraham AD; Ramirez DA; Lunghofer PJ; Pitts TM; Regan DP; Tan AC; Gustafson DL; Messersmith WA; LaBarbera DV
Mol Cancer Ther; 2020 Aug; 19(8):1598-1612. PubMed ID: 32499299
[TBL] [Abstract][Full Text] [Related]
4. CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma.
Li S; Chai Y; Ding Y; Yuan T; Wu C; Huang C
Oncol Rep; 2019 Aug; 42(2):657-669. PubMed ID: 31173252
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers: A meta-analysis.
Liu W; Xu J; Zhang C
Medicine (Baltimore); 2018 Jul; 97(29):e11522. PubMed ID: 30024537
[TBL] [Abstract][Full Text] [Related]
6. CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.
Li Y; He LR; Gao Y; Zhou NN; Liu Y; Zhou XK; Liu JF; Guan XY; Ma NF; Xie D
Cell Death Dis; 2019 Feb; 10(2):99. PubMed ID: 30718500
[TBL] [Abstract][Full Text] [Related]
7. Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
Mu QJ; Li HL; Yao Y; Liu SC; Yin CG; Ma XZ
PLoS One; 2015; 10(11):e0143030. PubMed ID: 26599012
[TBL] [Abstract][Full Text] [Related]
8. CHD1L promotes tumor progression and predicts survival in colorectal carcinoma.
Ji X; Li J; Zhu L; Cai J; Zhang J; Qu Y; Zhang H; Liu B; Zhao R; Zhu Z
J Surg Res; 2013 Nov; 185(1):84-91. PubMed ID: 23746766
[TBL] [Abstract][Full Text] [Related]
9. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.
Chen L; Chan TH; Yuan YF; Hu L; Huang J; Ma S; Wang J; Dong SS; Tang KH; Xie D; Li Y; Guan XY
J Clin Invest; 2010 Apr; 120(4):1178-91. PubMed ID: 20335658
[TBL] [Abstract][Full Text] [Related]
10. CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2.
He WP; Guo YY; Yang GP; Lai HL; Sun TT; Zhang ZW; Ouyang LL; Zheng Y; Tian LM; Li XH; You ZS; Xie D; Yang GF
Int J Med Sci; 2020; 17(15):2387-2395. PubMed ID: 32922205
[TBL] [Abstract][Full Text] [Related]
11. CHD1L Promotes Neuronal Differentiation in Human Embryonic Stem Cells by Upregulating PAX6.
Dou D; Zhao H; Li Z; Xu L; Xiong X; Wu X; Sun Y; Zeng S; Ouyang Q; Zhou D; Ma N; Lin G; Hu L
Stem Cells Dev; 2017 Nov; 26(22):1626-1636. PubMed ID: 28946814
[TBL] [Abstract][Full Text] [Related]
12. Effect of chromodomain helicase/ATPase DNA binding protein 1-like gene on the invasion and metastasis of tongue squamous cell carcinoma CAL27 cells.
Hu KL; Fan X; Hu WT; Li HL; Tang QH; Sun XH
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):81-87. PubMed ID: 33723941
[TBL] [Abstract][Full Text] [Related]
13. CHD1L: a novel oncogene.
Cheng W; Su Y; Xu F
Mol Cancer; 2013 Dec; 12(1):170. PubMed ID: 24359616
[TBL] [Abstract][Full Text] [Related]
14. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
[TBL] [Abstract][Full Text] [Related]
15. Chromodomain Helicase DNA Binding Protein 1-like, a negative regulator of Forkhead box O3a, promotes the proliferation and migration of Angiotensin II-induced vascular smooth muscle cells.
Zhang X; Sun Y
Bioengineered; 2022 Feb; 13(2):2597-2609. PubMed ID: 35001835
[TBL] [Abstract][Full Text] [Related]
16. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival.
Chen L; Hu L; Chan TH; Tsao GS; Xie D; Huo KK; Fu L; Ma S; Zheng BJ; Guan XY
Hepatology; 2009 Jul; 50(1):122-9. PubMed ID: 19441106
[TBL] [Abstract][Full Text] [Related]
17. Expression of CHD1L in bladder cancer and its influence on prognosis and survival.
Tian F; Xu F; Zhang ZY; Ge JP; Wei ZF; Xu XF; Cheng W
Tumour Biol; 2013 Dec; 34(6):3687-90. PubMed ID: 23807680
[TBL] [Abstract][Full Text] [Related]
18. Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development.
Chan TH; Chen L; Liu M; Hu L; Zheng BJ; Poon VK; Huang P; Yuan YF; Huang JD; Yang J; Tsao GS; Guan XY
Hepatology; 2012 Feb; 55(2):491-505. PubMed ID: 21953552
[TBL] [Abstract][Full Text] [Related]
19. CHD1L Regulates Cell Cycle, Apoptosis, and Migration in Glioma.
Sun J; Zhang L; Zhao H; Qiu X; Chen W; Wang D; Ban N; Fan S; Shen C; Xia X; Ji B; Wang Y
Cell Mol Neurobiol; 2016 May; 36(4):565-76. PubMed ID: 26162969
[TBL] [Abstract][Full Text] [Related]
20. CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors.
Liu M; Chen L; Ma NF; Chow RK; Li Y; Song Y; Chan TH; Fang S; Yang X; Xi S; Jiang L; Li Y; Zeng TT; Li Y; Yuan YF; Guan XY
Hepatology; 2016 May; 63(5):1544-59. PubMed ID: 27100146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
